Respiratory Muscle Assessment in Acute Guillain–Barré Syndrome

Lung

Volumn 194, Issue 5, 2016, Pages 821-828

  Walterspacher, S ^a,b,d   Kirchberger, A ^a   Lambeck, J ^a   Walker, D J ^a,b,d   Schworer A ^a   Niesen, W D ^a   Windisch, W ^a,b   Hamzei, F ^a,c   Kabitz, H J ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acute Inflammatory Demyelinating Polyneuropathy (AIDP); Diaphragm; Guillain Barr Syndrome; Intensive care; Respiratory muscle strength; Sniff nasal pressure; Vital capacity

Indexed keywords

BICARBONATE; CARBON DIOXIDE;

ADULT; ALKALOSIS; ARTERIAL PRESSURE; ARTICLE; BLOOD GAS ANALYSIS; BREATHING MUSCLE; CLINICAL ARTICLE; ELECTROPHYSIOLOGICAL ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; GBS DISABILITY SCORE; GOLD STANDARD; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; INSPIRATORY CAPACITY; INTENSIVE CARE UNIT; LUNG FUNCTION TEST; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE ASSESSMENT; MUSCULOSKELETAL SYSTEM EXAMINATION; NERVE STIMULATION; PEAK EXPIRATORY FLOW; PHRENIC NERVE; PRIORITY JOURNAL; SCORING SYSTEM; SPIROMETRY; VITAL CAPACITY; ACUTE DISEASE; AGED; DISABILITY; EXHALATION; INHALATION; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; AGED; DISABILITY EVALUATION; EXHALATION; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INHALATION; MALE; MIDDLE AGED; MUSCLE STRENGTH; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 84981287313     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9929-5     Document Type: Article

References (36)

1. Green DM (2005) Weakness in the ICU: Guillain Barre Syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy. Neurologist 11:338–347. doi:10.1097/01.nrl.0000163784.17602.57
2. Lawn ND, Fletcher DD, Henderson RD et al (2001) Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 58:893–898. doi:10.1001/archneur.58.6.893
3. Mehta S (2006) Neuromuscular disease causing acute respiratory failure. Respir Care 51:1016–1023
4. Durand M-C, Porcher R, Orlikowski D et al (2006) Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol 5:1021–1028. doi:10.1016/S1474-4422(06)70603-2
5. van Koningsveld R, Steyerberg EW, Hughes RA et al (2007) A clinical prognostic scoring system for Guillain–Barré syndrome. Lancet Neurol 6:589–594. doi:10.1016/S1474-4422(07)70130-8
6. Kleyweg RP, Van Der Meché FGA, Schmitz PIM (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 14:1103–1109. doi:10.1002/mus.880141111
7. Rochester DF, Arora NS (1983) Respiratory muscle failure. Med Clin North Am 67:573–597
8. American Thoracic Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624. doi:10.1164/rccm.166.4.518
9. WMA (2013) WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/30publications/10policies/b3/. Accessed 2 Jan 2014
10. Diener H-C (2012) Leitlinien für Diagnostik und Therapie in der Neurologie, 5., vollständig überarbeitete Auflage. Thieme, Stuttgart
11. Wanger J (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522. doi:10.1183/09031936.05.00035005
12. Miller MR (2005) Standardisation of spirometry. Eur Respir J 26:319–338. doi:10.1183/09031936.05.00034805
13. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381
14. Kabitz H-J, Windisch W (2007) Diagnostik der Atemmuskelfunktion: state of the Art. Pneumologie 61:582–587. doi:10.1055/s-2007-980080
15. Windisch W, Kabitz HJ, Sorichter S (2005) Influence of different trigger techniques on twitch mouth pressure during bilateral anterior magnetic phrenic nerve stimulation. CHEST J 128:190–195
16. Durand M-C, Lofaso F, Lefaucheur J-P et al (2003) Electrophysiology to predict mechanical ventilation in Guillain–Barré syndrome. Eur J Neurol 10:39–44. doi:10.1046/j.1468-1331.2003.00505.x
17. Zifko U, Chen R, Remtulla H et al (1996) Respiratory electrophysiological studies in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 60:191–194. doi:10.1136/jnnp.60.2.191
18. Steier J, Kaul S, Seymour J et al (2007) The value of multiple tests of respiratory muscle strength. Thorax 62:975–980. doi:10.1136/thx.2006.072884
19. Polkey MI, Moxham J (2001) Clinical aspects of respiratory muscle dysfunction in the critically ill*. Chest 119:926–939. doi:10.1378/chest.119.3.926
20. Terzi N, Orlikowski D, Fermanian C et al (2008) Measuring inspiratory muscle strength in neuromuscular disease: one test or two? Eur Respir J 31:93–98. doi:10.1183/09031936.00094707
21. Fitting JW, Paillex R, Hirt L et al (1999) Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 46:887–893
22. Prigent H, Orlikowski D, Letilly N et al (2012) Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barré Syndrome and myasthenia gravis. Neurocrit Care 17:236–239. doi:10.1007/s12028-011-9575-y
23. Orlikowski D, Prigent H, Sharshar T et al (2004) Respiratory dysfunction in guillain-barré syndrome. Neurocrit Care 1:415–422. doi:10.1385/NCC:1:4:415
24. Troyer AD, Borenstein S, Cordier R (1980) Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax 35:603–610. doi:10.1136/thx.35.8.603
25. Miller JM, Moxham J, Green M (1985) The maximal sniff in the assessment of diaphragm function in man. Clin Sci 69:91–96. doi:10.1042/cs0690091
26. Prigent H, Lejaille M, Falaize L et al (2004) Assessing inspiratory muscle strength by sniff nasal inspiratory pressure. Neurocrit Care 1:475–478. doi:10.1385/NCC:1:4:475
27. Fitting J-W (2006) Sniff nasal inspiratory pressure: simple or too simple? Eur Respir J 27:881–883. doi:10.1183/09031936.06.00007906
28. Stefanutti D, Benoist M-R, Scheinmann P et al (2000) Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 162:1507–1511. doi:10.1164/ajrccm.162.4.9910034
29. Capozzo R, Quaranta VN, Pellegrini F et al (2014) Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. J Neurol 262:593–603. doi:10.1007/s00415-014-7613-3
30. Lyall RA, Donaldson N, Polkey MI et al (2001) Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 124:2000–2013. doi:10.1093/brain/124.10.2000
31. Chaudri MB, Liu C, Watson L et al (2000) Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J 15:539–542
32. Chevrolet JC, Deléamont P (1991) Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain–Barré syndrome. Am Rev Respir Dis 144:814–818. doi:10.1164/ajrccm/144.4.814
33. Rieder P, Louis M, Jolliet P, Chevrolet JC (1995) The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 21:663–668
34. Walgaard C, Lingsma HF, Ruts L et al (2010) Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol 67:781–787. doi:10.1002/ana.21976
35. Hart N, Polkey MI, Sharshar T et al (2003) Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry 74:1685–1687. doi:10.1136/jnnp.74.12.1685
36. Bourke SC (2014) Respiratory involvement in neuromuscular disease. Clin Med 14:72–75. doi:10.7861/clinmedicine.14-1-72